REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc. et al
REGENXBIO Inc. and The Trustees of the University of Pennsylvania |
Sarepta Therapeutics, Inc., Sarepta Therapeutics Three, LLC and Catalent Inc. |
1:2023cv00667 |
June 20, 2023 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent |
35 U.S.C. § 271 Patent Infringement |
Plaintiff |
Docket Report
This docket was last retrieved on August 17, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 16 Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 9/27/2023, at 11:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/17/2023. (nms) |
Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Julie S. Goldemberg - filed by The Trustees of the University of Pennsylvania. (Attachments: #1 Certification of Julie S. Goldemberg)(Dudash, Amy) |
SO ORDERED, re #15 MOTION for Pro Hac Vice Appearance of Attorney Julie S. Goldemberg, filed by The Trustees of the University of Pennsylvania. Signed by Judge Richard G. Andrews on 5/15/2023. (nms) |
Filing 14 ANSWER to #1 Complaint, with Jury Demand by Catalent Inc..(Fahnestock, Derek) |
Filing 13 ANSWER to #1 Complaint, with Jury Demand by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc..(Fahnestock, Derek) |
Filing 12 MOTION for Pro Hac Vice Appearance of Attorney James E. Baker - filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, Robert B. Wilson, Anastasia M. Fernands, and Molly Moore - filed by Catalent Inc., Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, Robert B. Wilson, Anastasia M. Fernands, and Molly Moore, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc., Catalent Inc., #12 MOTION for Pro Hac Vice Appearance of Attorney James E. Baker, filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. Signed by Judge Richard G. Andrews on 8/7/2023. (nms) |
Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Catalent Inc.. (Fahnestock, Derek) |
Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent no parent corporation for Sarepta Therapeutics, Inc.; Corporate Parent Sarepta Therapeutics Inc. for Sarepta Therapeutics Three, LLC filed by Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) |
Filing 8 STIPULATION to Extend Time to Respond to Complaint - filed by Catalent Inc., Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc.. (Fahnestock, Derek) Modified on 7/6/2023 (nms). |
SO ORDERED, re #8 STIPULATION to Extend Time to Respond to Complaint (*Reset Answer Deadlines: Catalent Inc. answer due 8/10/2023; Sarepta Therapeutics Three, LLC answer due 8/10/2023; Sarepta Therapeutics, Inc. answer due 8/10/2023). Signed by Judge Richard G. Andrews on 7/6/2023. (nms) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Filing 7 SUMMONS Returned Executed by REGENXBIO Inc..Catalent Inc. served on 6/20/2023, answer due 7/11/2023; Sarepta Therapeutics Three, LLC served on 6/20/2023, answer due 7/11/2023; Sarepta Therapeutics, Inc. served on 6/20/2023, answer due 7/11/2023. (Morrison, Susan) |
Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (vfm) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by The Trustees of the University of Pennsylvania. (vfm) |
Filing 4 Disclosure Statement pursuant to Rule 7.1: Other Affiliate BlackRock, Inc. filed by REGENXBIO Inc.. (vfm) |
Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,680,274. (vfm) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
Filing 1 COMPLAINT for Patent Infringement and for Declaratory Judgment with Jury Demand against Catalent Inc., Sarepta Therapeutics Three, LLC, Sarepta Therapeutics, Inc. (Filing fee $ 402, receipt number ADEDC-4161146) - filed by The Trustees of the University of Pennsylvania, REGENXBIO Inc.. (Attachments: #1 Exhibits A-B, #2 Exhibits C-E, #3 Exhibits F-Q, #4 Civil Cover Sheet) (vfm) Modified on 6/21/2023 (nms). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.